4D Molecular Therapeutics (FDMT) EBITDA Margin (QoQ) (2020 - 2026)
4D Molecular Therapeutics (FDMT) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | 4D Molecular Therapeutics | 856.62 Mn | 495.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37,899.00 |
| Mar 31, 2026 | -243,344.00 |
| Dec 31, 2025 | 6.80 Mn |
| Sep 30, 2025 | 32.84 Mn |
| Jun 30, 2025 | -1.34 Mn |
| Mar 31, 2025 | 522.87 Mn |
| Dec 31, 2024 | -390.73 Mn |
| Sep 30, 2024 | -85.53 Mn |
| Jun 30, 2024 | -71.29 Mn |
| Mar 31, 2024 | -32.91 Mn |
| Dec 31, 2023 | 19.30 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | -334,334.00 |
| Mar 31, 2023 | -779,956.00 |
| Dec 31, 2022 | 299,587.00 |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | -1.54 Mn |
| Mar 31, 2022 | 2.48 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Sep 30, 2021 | -160,683.00 |